DoseGear research brief
Synthetic tripeptide developed by Professor Vladimir Khavinson, supporting cartilage, connective tissue, and cellular regeneration through proliferation markers and apoptosis pathway modulation.
AED peptide
Bioregulatory Tripeptide | Cartilage & Connective Tissue Support
DoseGear research brief
Synthetic tripeptide developed by Professor Vladimir Khavinson, supporting cartilage, connective tissue, and cellular regeneration through proliferation markers and apoptosis pathway modulation.
Modulates cell proliferation, suppresses apoptosis, affects fibroblast activity, reduces senescence markers, and influences extracellular matrix preservation.
Compound background
Study windows describe what researchers measured, not when an individual should expect a result.
Synthetic tripeptide attributed to Vladimir Khavinson.
Cartilage, connective-tissue, and cellular-senescence research involving proliferation, apoptosis, and matrix remodeling.
The source reports cell-culture observations at 72 hours, five days, and seven days; underlying study identification is incomplete.
Reference data
Not personalized dosing instructions
Only injectable vial references are shown. Nasal, topical, and unsupported non-vial schedules are excluded.
| Research context | Amount | Frequency | Route |
|---|---|---|---|
| Chart reference | 2 mg | Daily · See source guide | Injectable · 20 mg lyophilized vial + 3 mL BAC Water |
Reference cycle
1-3 months depending on application
Reference storage
Injectable lyophilized: 2-8°C; Reconstituted: 2-8°C refrigerated
Fibroblast Proliferation Study
Kidney Cell Culture Research
Clinical Spine & Joint Study (Russia)
Matrix Metalloproteinase Research
This DoseGear profile combines published scientific literature with lyophilized-vial protocol references. Citations are provided for independent review.